Filing Details

Accession Number:
0001493152-19-015510
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-15 16:30:27
Reporting Period:
2019-10-11
Accepted Time:
2019-10-15 16:30:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1076682 Polarityte Inc. PTE Biological Products, (No Disgnostic Substances) (2836) 061529524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1656557 Richard Hague 123 Wright Brothers Drive
Salt Lake City UT 84116
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-10-11 3,885 $2.85 333,538 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. In April 2019 the reporting persons was awarded restricted stock units that vest in four equal installments every six months subject to continued service, so 8,750 vested October 8, 2019. The reported sale was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 13, 2019, as amended August 29, 2019, and is intended to cover withholding taxes resulting from the restricted stock units that vested on October 8, 2019.